Skip to main content

2025 PharmSci 360 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Dong Ho Oh, Ph.D.

Researcher
Daewon Pharm. Co., Ltd., Republic of Korea

Poster(s):

(W0930-08-50) Formulation Process Development of a Novel Combination Analgesic Based on Risk Assessment (RA) and Design of Experiments (DoE)

Wednesday, November 12, 2025
9:30 AM - 10:30 AM CT